Cargando…
Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275655/ https://www.ncbi.nlm.nih.gov/pubmed/32506216 http://dx.doi.org/10.1007/s00228-020-02920-1 |
_version_ | 1783542831794618368 |
---|---|
author | Montastruc, Jean-Louis Rousseau, Vanessa Durrieu, Geneviève Bagheri, Haleh |
author_facet | Montastruc, Jean-Louis Rousseau, Vanessa Durrieu, Geneviève Bagheri, Haleh |
author_sort | Montastruc, Jean-Louis |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7275655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-72756552020-06-08 Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase® Montastruc, Jean-Louis Rousseau, Vanessa Durrieu, Geneviève Bagheri, Haleh Eur J Clin Pharmacol Letter to the Editor Springer Berlin Heidelberg 2020-06-06 2020 /pmc/articles/PMC7275655/ /pubmed/32506216 http://dx.doi.org/10.1007/s00228-020-02920-1 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editor Montastruc, Jean-Louis Rousseau, Vanessa Durrieu, Geneviève Bagheri, Haleh Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase® |
title | Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase® |
title_full | Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase® |
title_fullStr | Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase® |
title_full_unstemmed | Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase® |
title_short | Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase® |
title_sort | serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in vigibase® |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275655/ https://www.ncbi.nlm.nih.gov/pubmed/32506216 http://dx.doi.org/10.1007/s00228-020-02920-1 |
work_keys_str_mv | AT montastrucjeanlouis seriousadversedrugreactionswithhydroxychloroquineapharmacovigilancestudyinvigibase AT rousseauvanessa seriousadversedrugreactionswithhydroxychloroquineapharmacovigilancestudyinvigibase AT durrieugenevieve seriousadversedrugreactionswithhydroxychloroquineapharmacovigilancestudyinvigibase AT bagherihaleh seriousadversedrugreactionswithhydroxychloroquineapharmacovigilancestudyinvigibase |